risperidone has been researched along with Urinary Retention in 5 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of urinary retention emerging after fluoxetine (20 mg/day) addition to low risperidone doses (2 mg/day) is presented." | 7.71 | Urinary retention caused after fluoxetine-risperidone combination. ( Bozikas, V; Karavatos, A; Petrikis, P, 2001) |
| "Priapism was relieved when a hematoma was evacuated from his penis." | 5.29 | [Risperidone-induced priapism]. ( Knobler, HY; Maizel, S; Umansky, L, 1996) |
| "Several adverse outcomes attributed to atypical antipsychotic drugs, specifically quetiapine, risperidone, and olanzapine, are known to cause acute kidney injury (AKI)." | 3.80 | Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. ( Dixon, SN; Gandhi, S; Garg, AX; Hwang, YJ; Nash, DM; Pannu, N; Parikh, CR; Rehman, F; Reiss, JP; Shariff, SZ; Wald, R, 2014) |
| "A case of urinary retention emerging after fluoxetine (20 mg/day) addition to low risperidone doses (2 mg/day) is presented." | 3.71 | Urinary retention caused after fluoxetine-risperidone combination. ( Bozikas, V; Karavatos, A; Petrikis, P, 2001) |
| "Priapism was relieved when a hematoma was evacuated from his penis." | 1.29 | [Risperidone-induced priapism]. ( Knobler, HY; Maizel, S; Umansky, L, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ou, H | 1 |
| Chang, HA | 1 |
| Kao, YC | 1 |
| Tzeng, NS | 1 |
| Hwang, YJ | 1 |
| Dixon, SN | 1 |
| Reiss, JP | 1 |
| Wald, R | 1 |
| Parikh, CR | 1 |
| Gandhi, S | 1 |
| Shariff, SZ | 1 |
| Pannu, N | 1 |
| Nash, DM | 1 |
| Rehman, F | 1 |
| Garg, AX | 1 |
| Maizel, S | 1 |
| Umansky, L | 1 |
| Knobler, HY | 1 |
| Siepmann, M | 1 |
| Olbrich, H | 1 |
| Bozikas, V | 1 |
| Petrikis, P | 1 |
| Karavatos, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pragmatic Randomized-controlled Trial of a Multi-pronged Electronic Health Record-based Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions Among Older Adults With Alzheimer's and Related Dementias[NCT04851691] | 117 participants (Anticipated) | Interventional | 2021-08-03 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for risperidone and Urinary Retention
| Article | Year |
|---|---|
Risperidone-Induced Acute Urinary Retention in a Patient With Major Depressive Disorder With Psychotic Features: a Case Report.
Topics: Antipsychotic Agents; Depressive Disorder, Major; Humans; Psychotic Disorders; Risperidone; Urinary | 2021 |
Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Ca | 2014 |
[Risperidone-induced priapism].
Topics: Adult; Antipsychotic Agents; Hematoma; Humans; Male; Penile Diseases; Priapism; Risperidone; Schizop | 1996 |
[Urinary retention with risperidone].
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Male; Risperidone; Schizophre | 1997 |
Urinary retention caused after fluoxetine-risperidone combination.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Delusions; D | 2001 |